Ubiquitination of PTEN (Phosphatase and Tensin Homolog) Inhibits Phosphatase Activity and Is Enhanced by Membrane Targeting and Hyperosmotic Stress

被引:44
作者
Maccario, Helene [1 ]
Perera, Nevin M. [1 ]
Gray, Alexander [1 ]
Downes, C. Peter [1 ]
Leslie, Nick R. [1 ]
机构
[1] Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland
基金
英国医学研究理事会;
关键词
TUMOR-SUPPRESSOR PTEN; PROTEIN-KINASE CK2; C-TERMINUS; B-ALPHA; PHOSPHORYLATION; ACTIVATION; PROTEASOME; STABILITY; PATHWAY; CANCER;
D O I
10.1074/jbc.M109.072280
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The PTEN (phosphatase and tensin homolog) tumor suppressor is a phosphatase that inhibits phosphoinositide 3-kinase-dependent signaling by metabolizing the phosphoinositide lipid phosphatidylinositol 3,4,5-trisphosphate (PtdInsP(3)) at the plasma membrane. PTEN can be mono-or polyubiquitinated, and this appears to control its nuclear localization and stability, respectively. Although PTEN phosphorylation at a cluster of C-terminal serine and threonine residues has been shown to stabilize the protein and inhibit polyubiquitination and plasma membrane localization, details of the regulation of ubiquitination are unclear. Here, we show that plasma membrane targeting of PTEN greatly enhances PTEN ubiquitination and that phosphorylation of PTEN in vitro does not affect subsequent ubiquitination. These data suggest that C-terminal phosphorylation indirectly regulates ubiquitination by controlling membrane localization. We also show that either mono-or polyubiquitination in vitro greatly reduces PTEN phosphatase activity. Finally, we show that hyperosmotic stress increases both PTEN ubiquitination and cellular PtdInsP(3) levels well before a reduction in PTEN protein levels is observed. Both PTEN ubiquitination and elevated PtdInsP(3) levels were reduced within 10 min after removal of the hyperosmotic stress. Our data indicate that ubiquitination may represent a regulated mechanism of direct reversible control over the PTEN enzyme.
引用
收藏
页码:12620 / 12628
页数:9
相关论文
共 42 条
[1]   Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity [J].
Cao, Juxiang ;
Schulte, Jennifer ;
Knight, Alexander ;
Leslie, Nicholas R. ;
Zagozdzon, Agnieszka ;
Bronson, Roderick ;
Manevich, Yefim ;
Beeson, Craig ;
Neumann, Carola A. .
EMBO JOURNAL, 2009, 28 (10) :1505-1517
[2]   The PTEN-PI3K pathway: of feedbacks and cross-talks [J].
Carracedo, A. ;
Pandolfi, P. P. .
ONCOGENE, 2008, 27 (41) :5527-5541
[3]   Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics [J].
Crockett, DK ;
Fillmore, GC ;
Elenitoba-Johnson, KSJ ;
Lim, MS .
PROTEOMICS, 2005, 5 (05) :1250-1262
[4]   Membrane-binding and activation mechanism of PTEN [J].
Das, S ;
Dixon, JE ;
Cho, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7491-7496
[5]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[6]   Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a [J].
Fine, Barry ;
Hodakoski, Cindy ;
Koujak, Susan ;
Su, Tao ;
Saal, Lao H. ;
Maurer, Matthew ;
Hopkins, Benjamin ;
Keniry, Megan ;
Sulis, Maria Luisa ;
Mense, Sarah ;
Hibshoosh, Hanina ;
Parsons, Ramon .
SCIENCE, 2009, 325 (5945) :1261-1265
[7]   The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization [J].
Fouladkou, Fatemeh ;
Landry, Tamara ;
Kawabe, Hiroshi ;
Neeb, Antje ;
Lu, Chen ;
Brose, Nils ;
Stambolic, Vuk ;
Rotin, Daniela .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (25) :8585-8590
[8]   Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts [J].
Gray, A ;
Olsson, H ;
Batty, IH ;
Priganica, L ;
Downes, CP .
ANALYTICAL BIOCHEMISTRY, 2003, 313 (02) :234-245
[9]   The role of PTEN signaling perturbations in cancer and in targeted therapy [J].
Keniry, M. ;
Parsons, R. .
ONCOGENE, 2008, 27 (41) :5477-5485
[10]   Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression [J].
Kwabi-Addo, B ;
Giri, D ;
Schmidt, K ;
Podsypanina, K ;
Parsons, R ;
Greenberg, N ;
Ittmann, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11563-11568